Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | Three months ended / March 31, 2026 | Three months ended / March 31, 2025 |
|---|---|---|
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchases of investment securities | (554,428) | (391,204) |
| Proceeds from sales and maturities of investment securities | 302,889 | 306,482 |
| Purchases of property and equipment | (820) | (1,239) |
| Net cash used in investing activities | (252,359) | (85,961) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from issuance of common stock, net of commissions | 380,514 | — |
| Offering costs related to issuance of common stock | (578) | — |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's capex?
- Crinetics Pharmaceuticals (CRNX) reported capex of $820K in Q1 2026.
- How has Crinetics Pharmaceuticals's capex changed year-over-year?
- Crinetics Pharmaceuticals's capex decreased by 33.8% year-over-year, from $1.24M to $820K.
- What is the long-term trend for Crinetics Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's capex has grown at a 90.7% compound annual growth rate (CAGR), from $436K to $5.76M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Crinetics Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude